Support and Resistance Basics

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

EHC


Top 10 Correlated ETFs

EHC


Top 10 Correlated Stocks

EHC


In the News

02:18 13 Aug 2022 EHC

Encompass Health (EHC) Up 4.7% Despite Q2 Earnings Miss

Encompass Health (EHC) intends to open three additional de novo locations and increase the bed count by 20 in existing facilities this year.

08:06 13 Aug 2022 EHC

Encompass Health Encompasses Quality, Defensibility After Q2 FY22

Encompass Health posted Q2 FY22 earnings last week with downsides relative to consensus at the top and bottom line. Despite this, FCF remained buoyant and the company did recognize growth in most segments.

03:18 13 Aug 2022 EHC

Encompass Health Corporation (EHC) CEO Mark Tarr on Q2 2022 Results - Earnings Call Transcript

Encompass Health Corporation (NYSE:EHC ) Q2 2022 Earnings Conference Call August 2, 2022 10:00 AM ET Company Participants Mark Miller - Chief IR Officer Mark Tarr - President and CEO Doug Coltharp - CFO Patrick Darby - General Counsel and Corporate Secretary Conference Call Participants Andrew Mok - UBS Joanna Gajuk - Bank of America Brian Tanquilut - Jefferies John Ransom - Raymond James Pito Chickering - Deutsche Bank Matthew Borsch - BMO Capital Markets Sarah James - Barclays Operator Good morning, everyone, and welcome to Encompass Health's Second Quarter 2022 Earnings Conference Call. [Operator Instructions] I will now turn the call over to Mark Miller, Encompass Health's Chief Investor Relations Officer.

08:08 13 Aug 2022 EHC

Encompass Health (EHC) Q2 Earnings and Revenues Miss Estimates

Encompass Health (EHC) delivered earnings and revenue surprises of -8.25% and 1.39%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

11:35 13 Aug 2022 EHC

Analysts Estimate Encompass Health (EHC) to Report a Decline in Earnings: What to Look Out for

Encompass Health (EHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

06:25 13 Aug 2022 EHC

Encompass Health (EHC) to Build New Rehab Unit in Missouri

Encompass Health (EHC) and BJC HealthCare's new rehabilitation hospital is expected to come online in 2024.

12:42 13 Aug 2022 EHC

Encompass Health (EHC) Opens EHR-Backed Hospital in Florida

Encompass Health (EHC) takes its U.S. inpatient rehabilitation hospital count to 150 with the opening of a hospital in Florida integrated with the sound EHR system of Oracle Cerner.

05:43 13 Aug 2022 EHC

Encompass Health (EHC) Forms JV With NCH Healthcare in Naples

The NCH Healthcare System's board grants approval to invest in the joint venture with Encompass Health (EHC).

10:16 13 Aug 2022 EHC

Four value-stock picks from a fund manager who steers clear of the energy sector

Jensen Investment Management follows a simple rule for initial screenings of stocks: Companies need to have achieved returns on equity (ROE) of at least 15% annually, for at least 10 consecutive years.

04:12 13 Aug 2022 EHC

Encompass Health (EHC) Plans to Distribute Enhabit Shares

Every Encompass Health (EHC) shareholder will receive one Enhabit common share for every two EHC common shares held.

Financial details

Company Rating
Strong Buy
Market Cap
5.28B
Income
327.8M
Revenue
5.27B
Book val./share
20.19
Cash/share
1.88
Dividend
1.12
Dividend %
2.08%
Employees
28K
Optionable
No
Shortable
Yes
Earnings
25 Oct 2022
P/E
16.46
Forward P/E
11.21
PEG
10.99
P/S
1.01
P/B
2.67
P/C
28.63
P/FCF
26.5
Quick Ratio
1.01
Current Ratio
1.24
Debt / Equity
1.72
LT Debt / Equity
1.35
-
-
EPS (TTM)
3.3
EPS next Y
4.8
EPS next Q
1.2
EPS this Y
44.6%
EPS next Y
45.45%
EPS next 5Y
45.45%
EPS last 5Y
8.74%
Revenue last 5Y
5.5%
Revenue Q/Q
-0.23%
EPS Q/Q
-44.32%
-
-
-
-
SMA20
8.97%
SMA50
2.55%
SMA100
-3.44%
Inst Own
92.98%
Inst Trans
2.15%
ROA
5%
ROE
17%
ROC
0.12%
Gross Margin
96%
Oper. Margin
14%
Profit Margin
6%
Payout
34%
Shs Outstand
99.78M
Shs Float
97.79M
-
-
-
-
Target Price
88.25
52W Range
42.187748-64.797134
52W High
-15.91%
52W Low
+28.14%
RSI
68.44
Rel Volume
0.71
Avg Volume
1.03M
Volume
726.02K
Perf Week
0.88%
Perf Month
20.7%
Perf Quarter
2.64%
Perf Half Y
6.22%
-
-
-
-
Beta
1.00085
-
-
Volatility
0.58%, 1.99%
Prev Close
1.8%
Price
53.82
Change
1.45%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
41.8243.6946.9947.151.94
Net income per share
2.742.993.662.884.18
Operating cash flow per share
7.017.796.487.157.26
Free cash flow per share
4.45.022.363.011.67
Cash per share
0.580.710.972.270.56
Book value per share
12.6113.0413.816.1119.38
Tangible book value per share
-10.15-10.08-11.11-7.91-4.53
Share holders equity per share
12.6113.0413.816.1119.38
Interest debt per share
29.1627.1933.2937.837.55
Market cap
3.97B5.19B6.02B6.31B4.87B
Enterprise value
6.5B7.64B9.03B9.63B8.35B
P/E ratio
15.517.7716.7922.1911.81
Price to sales ratio
1.011.211.311.360.95
POCF ratio
6.056.819.488.956.8
PFCF ratio
9.6410.5626.0521.2729.57
P/B Ratio
3.364.074.453.972.55
PTB ratio
3.364.074.453.972.55
EV to sales
1.661.791.962.071.63
Enterprise value over EBITDA
8.610.0810.5911.818.58
EV to operating cash flow
9.8810.0214.2113.6611.67
EV to free cash flow
15.7615.5339.0632.4750.74
Earnings yield
0.060.060.060.050.08
Free cash flow yield
0.10.090.040.050.03
Debt to equity
2.151.942.242.181.81
Debt to assets
0.710.70.720.690.65
Net debt to EBITDA
3.343.233.534.073.58
Current ratio
1.360.981.051.321.23
Interest coverage
4.214.634.343.524.9
Income quality
2.562.611.772.481.74
Dividend Yield
0.020.020.020.020.02
Payout ratio
0.360.340.30.390.27
Sales general and administrative to revenue
0.610.620.630.630.62
Research and developement to revenue
00000
Intangibles to total assets
0.490.490.460.430.41
Capex to operating cash flow
-0.37-0.35-0.64-0.58-0.77
Capex to revenue
-0.06-0.06-0.09-0.09-0.11
Capex to depreciation
-1.33-1.35-1.85-1.68-2.15
Stock based compensation to revenue
0.010.020.020.010.01
Graham number
27.8629.633.7132.3242.7
ROIC
0.150.150.130.110.13
Return on tangible assets
0.10.110.110.080.1
Graham Net
-32.66-32.67-39.93-38.77-39.56
Working capital
184.7M-10.4M34.8M231.3M172.6M
Tangible asset value
-951.1M-987.2M-1.09B-780M-446.2M
Net current asset value
-2.77B-2.96B-3.63B-3.53B-3.54B
Invested capital
2.181.972.292.231.85
Average receivables
522.45M520.25M539.45M572.8M626.55M
Average payables
96.7M102.5M104.8M115M126.3M
Average inventory
00000
Days sales outstanding
43.9739.9140.1145.0248.48
Days payables outstanding
191.67206.99205.65209.35239.96
Days of inventory on hand
00000
Receivables turnover
8.39.159.18.117.53
Payables turnover
1.91.761.771.741.52
Inventory turnover
00000
ROE
0.220.230.270.180.22
Capex per share
-2.61-2.76-4.12-4.14-5.59

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
Revenue per share
13.0112.9813.3213.4413.41
Net income per share
1.141.010.930.880.49
Operating cash flow per share
2.581.791.252.212.47
Free cash flow per share
1.330.52-0.791.051.26
Cash per share
0.740.960.550.951.88
Book value per share
17.818.6119.3119.8920.19
Tangible book value per share
-6.45-5.54-4.51-3.79-3.13
Share holders equity per share
17.818.6119.3119.8920.19
Interest debt per share
35.0435.3236.1435.7936.21
Market cap
6.15B5.91B5.14B5.61B4.42B
Enterprise value
9.5B9.27B8.62B9.03B7.77B
P/E ratio
13.5614.7814.0316.0322.71
Price to sales ratio
4.774.63.94.213.32
POCF ratio
24.0233.2841.5225.6418.08
PFCF ratio
46.56115.88-65.8154.1235.42
P/B Ratio
3.493.212.692.842.21
PTB ratio
3.493.212.692.842.21
EV to sales
7.387.226.546.775.84
Enterprise value over EBITDA
36.8238.8137.6640.2234.43
EV to operating cash flow
37.1252.2169.6541.2431.76
EV to free cash flow
71.97181.81-110.4187.0662.2
Earnings yield
0.020.020.020.020.01
Free cash flow yield
0.020.01-0.020.020.03
Debt to equity
1.881.821.811.741.72
Debt to assets
0.670.660.650.640.64
Net debt to EBITDA
1314.0715.2115.2214.83
Current ratio
1.071.151.231.261.24
Interest coverage
5.2454.54.642.67
Income quality
2.261.781.352.55.02
Dividend Yield
000.010.010.01
Payout ratio
0.250.280.30.330.57
Sales general and administrative to revenue
0.610.620.640.630.64
Research and developement to revenue
00000
Intangibles to total assets
0.430.420.410.410.4
Capex to operating cash flow
-0.48-0.71-1.63-0.53-0.49
Capex to revenue
-0.1-0.1-0.15-0.09-0.09
Capex to depreciation
-1.95-1.95-3.07-1.74-1.74
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
21.4120.5720.0519.8714.93
ROIC
0.040.030.030.030.03
Return on tangible assets
0.030.030.020.020.01
Graham Net
-38.99-38.94-39.4-38.77-38.88
Working capital
54.8M115.9M172.6M195.2M197M
Tangible asset value
-638.8M-548.4M-446.2M-375.5M-310.3M
Net current asset value
-3.54B-3.52B-3.54B-3.5B-3.51B
Invested capital
1.951.881.851.781.76
Average receivables
655.5M660.65M681.9M683.5M671.1M
Average payables
146.2M148.35M142.45M147.3M142.8M
Average inventory
00000
Days sales outstanding
43.8644.6846.4346.1344.56
Days payables outstanding
261.18252.74228.49236.31235.74
Days of inventory on hand
00000
Receivables turnover
2.052.011.941.952.02
Payables turnover
0.340.360.390.380.38
Inventory turnover
00000
ROE
0.060.050.050.040.02
Capex per share
-1.25-1.28-2.04-1.16-1.21

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap